|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Non-cash operating lease expense | |||||
| Unrealized (gain) loss on derivative instruments | |||||
| Unrealized (gain) loss on securities | |||||
| Total unrealized (gain) loss on securities | |||||
| Unrealized (gain) loss on Agency interest-only securities | |||||
| Provision for (release of) loan loss reserves, net | |||||
| Amortization of equity based compensation | |||||
| Amortization of deferred financing costs included in interest expense | |||||
| Amortization of (premium)/discount on mortgage loan financing included in interest expense | |||||
| Amortization of above- and below-market lease intangibles | |||||
| (Accretion)/amortization of discount, premium and other fees on mortgage loans receivable | |||||
| (Accretion)/amortization of discount and premium on securities | |||||
| Net result from mortgage loan receivables held for sale | |||||
| Realized (gain) loss on disposition of loan via foreclosure | |||||
| Realized (gain) loss on securities | |||||
| (Gain) loss on real estate, net | |||||
| Realized (gain) loss on sale of derivative instruments | |||||
| (Earnings) loss from investments in unconsolidated ventures in excess of distributions received | |||||
| Insurance proceeds for remediation work due to property damage | |||||
| Insurance proceeds used for remediation work due to property damage | |||||
| Origination of mortgage loan receivables held for sale | |||||
| Repayment of mortgage loan receivables held for sale | |||||
| Proceeds from sales of mortgage loan receivables held for sale | |||||
| Change in deferred tax liability | |||||
| Changes in operating assets and liabilities: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Origination and funding of mortgage loan receivables held for investment | |||||
| Purchases of mortgage loan receivables held for investment | |||||
| Repayment of mortgage loan receivables held for investment | |||||
| Proceeds from sale of mortgage loan receivables held for investment | |||||
| Purchases of securities | |||||
| Repayment of securities | |||||
| Basis recovery of interest-only securities | |||||
| Proceeds from sales of securities | |||||
| Purchases of real estate | |||||
| Capital improvements of real estate | |||||
| Proceeds from sale of real estate | |||||
| Capital contributions and advances to investment in unconsolidated joint ventures | |||||
| Capital distribution from investment in unconsolidated ventures | |||||
| Proceeds from FHLB stock | |||||
| Purchase of derivative instruments | |||||
| Sale of derivative instruments | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Deferred financing costs paid | |||||
| Proceeds from borrowings under debt obligations | |||||
| Repayment and repurchase of borrowings under debt obligations | |||||
| Cash dividends paid to Class A common shareholders | |||||
| Capital contributed by noncontrolling interests in consolidated ventures | |||||
| Consolidated Joint Venture | |||||
| Total capital contributed by noncontrolling interests in consolidated ventures | |||||
| Capital distributed to noncontrolling interests in consolidated ventures | |||||
| Consolidated Joint Venture | |||||
| Total capital distributed to noncontrolling interests in consolidated ventures | |||||
| Re-issuance of treasury stock | |||||
| Payment of liability assumed in exchange for shares for the minimum withholding taxes on vesting restricted stock | |||||
| Repurchase of treasury stock | |||||
| Issuance of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental information: | |||||
| Cash paid (received) for income taxes | |||||
| Cash paid for interest, net of amounts capitalized | |||||
| Non-cash investing and financing activities: | |||||
| Securities and derivatives sold, not settled | |||||
| Securities purchased, not settled | |||||
| Repurchase of treasury stock, not settled | |||||
| Repayments in transit of securities (other assets) | |||||
| Repayment in transit of mortgage loans receivable held for investment (other assets) | |||||
| Non-cash disposition of loans via foreclosure | |||||
| Real estate and real estate held for sale acquired in settlement of mortgage loans receivable held for investment, net | |||||
| Net settlement of sale of real estate, subject to debt - real estate | |||||
| Net settlement of sale of real estate, subject to debt - debt obligations | |||||
| Real estate acquired in former unconsolidated venture agreement | |||||
| Transfer of real estate, net into real estate held for sale | |||||
| Dividends declared, not paid | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Short-term unsettled U.S. Treasury securities classified in other assets on the consolidated balance sheet | |||||
Loading...
